Brought to you by

Incline licenses Ionsys from J&J's Alza
28 Feb 2014
Executive Summary
Incline Therapeutics Inc. has licensed exclusive worldwide rights to Ionsys (fentanyl iontophoretic transdermal system) from Johnson & Johnson's Alza Corp.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Transdermal
-
Drug Delivery
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
- Reverse Licensing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com